Biogen Inc (BIIB)
213.46
-2.67
(-1.24%)
USD |
NASDAQ |
May 02, 16:00
213.46
0.00 (0.00%)
After-Hours: 16:12
Biogen Cash from Operations (Quarterly): 553.20M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 553.20M |
| December 31, 2023 | 12.50M |
| September 30, 2023 | 592.40M |
| June 30, 2023 | 487.00M |
| March 31, 2023 | 455.30M |
| December 31, 2022 | -175.00M |
| September 30, 2022 | 661.00M |
| June 30, 2022 | 736.50M |
| March 31, 2022 | 161.80M |
| December 31, 2021 | 838.30M |
| September 30, 2021 | 805.30M |
| June 30, 2021 | 1.227B |
| March 31, 2021 | 769.00M |
| December 31, 2020 | -367.10M |
| September 30, 2020 | 1.181B |
| June 30, 2020 | 1.948B |
| March 31, 2020 | 1.467B |
| December 31, 2019 | 1.960B |
| September 30, 2019 | 1.695B |
| June 30, 2019 | 1.964B |
| March 31, 2019 | 1.460B |
| December 31, 2018 | 1.895B |
| September 30, 2018 | 1.736B |
| June 30, 2018 | 1.099B |
| March 31, 2018 | 1.457B |
| Date | Value |
|---|---|
| December 31, 2017 | 1.518B |
| September 30, 2017 | 1.628B |
| June 30, 2017 | 1.169B |
| March 31, 2017 | 235.20M |
| December 31, 2016 | 1.582B |
| September 30, 2016 | 991.30M |
| June 30, 2016 | 998.20M |
| March 31, 2016 | 1.016B |
| December 31, 2015 | 1.244B |
| September 30, 2015 | 895.40M |
| June 30, 2015 | 1.047B |
| March 31, 2015 | 733.00M |
| December 31, 2014 | 932.85M |
| September 30, 2014 | 914.03M |
| June 30, 2014 | 990.59M |
| March 31, 2014 | 104.63M |
| December 31, 2013 | 869.03M |
| September 30, 2013 | 671.92M |
| June 30, 2013 | 625.21M |
| March 31, 2013 | 178.94M |
| December 31, 2012 | 507.91M |
| September 30, 2012 | 541.78M |
| June 30, 2012 | 635.58M |
| March 31, 2012 | 194.62M |
| December 31, 2011 | 473.97M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-367.10M
Minimum
Dec 2020
1.964B
Maximum
Jun 2019
848.68M
Average
752.75M
Median
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly and Co | 1.166B |
| Bristol-Myers Squibb Co | 2.834B |
| Gilead Sciences Inc | 2.219B |
| AbbVie Inc | 4.753B |
| Sage Therapeutics Inc | -37.83M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -66.00M |
| Cash from Financing (Quarterly) | -439.60M |
| Free Cash Flow | 1.284B |
| Free Cash Flow Per Share (Quarterly) | 2.963 |
| Free Cash Flow to Equity (Quarterly) | 830.40M |
| Free Cash Flow to Firm (Quarterly) | 476.14M |
| Free Cash Flow Yield | 4.13% |